cas 37570-94-8|| where to buy 1,1'-Dimethyl-1H,1'H-2,2'-biimidazole

Produktname:1,1'-Dimethyl-1H,1'H-2,2'-biimidazole

IUPAC Name:1,1'-dimethyl-1H,1'H-2,2'-biimidazole

Packungseinheit	Verfügbarer Vorrat	Preis($)
CM519171-50mg	in stock	ǜƎȺ
CM519171-100mg	in stock	ǜƦƀ
CM519171-250mg	in stock	ƎƎȺ
CM519171-1g	1-2 Weeks	ǊƦư

Nur für den Einsatz in Forschung und Entwicklung..

Anfrage-Formular

Chemische Bezeichnung

CAS-Nummer

Menge*

Erforderliche Spezifikationen*
(Gehalt %, Materialqualität etc.)

Name des Ansprechpartners*

E-Mail des Ansprechpartners*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 37570-94-8 regularly via the above email.

Zusätzliche Hinweise

Verification code*

refresh

: CAS-Nr.:37570-94-8; Molekulare Formel:C8H10N4; Schmelzpunkt:-; SMILES-Code:CN1C=CN=C1C2=NC=CN2C; Dichte:

: Katalognummer:CM519171; Molekulargewicht:162.2; Siedepunkt:; Mdl-Nr.:MFCD00482464; Lagerung:Sealed in dry,Room Temperature

: Imidazoles; Imidazole is an important five-membered nitrogen-containing heterocyclic compound. Among the numerous heterocyclic compounds, imidazole and its derivatives are regarded as a unique and multifaceted scaffold material due to their diverse applications in industrial, organic and pharmaceutical chemistry. Imidazoles interact in different ways with many therapeutic targets, enzymes and receptors in biological systems and thus exhibit a wide range of biological activities. In particular, several imidazoles can be used as clinical drugs to treat various types of cancer with high therapeutic efficacy. Furthermore, imidazoles are one of the most critical segments in the field of anti-covid-19 virus drug discovery due to their ability to interact with active targets in living systems.; Imidazole Manufacturer; As a professional imidazole manufacturer, we can guarantee product quality and delivery time.our company has been committed to supply personalized product solutions to customers,pls consult us.